Concepedia

Mark Hertzberg

MH

Statistics

Publications

117

Citations

8K

H-Index

41

Active since

1992

Affiliations

Westmead Hospital(Current)

Prince of Wales Hospital

The University of Sydney

Royal North Shore Hospital

The University of Melbourne

Mark Hertzberg is an author at Westmead Hospital specializing in medicine, oncology, and hematology.

ORCID

Publications per year

1992–2025

117

Publications

117

Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Laurie H. Sehn, Alex F. Herrera, Christopher R. Flowers et al. · Journal of Clinical Oncology · 2019 · 772 citations · Full text

, , +14

Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Michael Dickinson, Carmelo Carlo‐Stella, Franck Morschhauser et al. · New England Journal of Medicine · 2022 · 676 citations · Full text

, , +16

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study

Ian W. Flinn, Richard van der Jagt, Brad S. Kahl et al. · Blood · 2014 · 638 citations · Full text

, , +3

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

Harry Iland, Ken Bradstock, Shane G. Supple et al. · Blood · 2012 · 340 citations · Full text

, , +15

Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing

David M. Kurtz, Michael R. Green, Scott V. Bratman et al. · Blood · 2015 · 340 citations

, , +11

1–5 of 117